Transfer of valproic acid and its main active unsaturated metabolite to the gestational tissue: Correlation with neural tube defect formation in the mouse
- 1 February 1986
- journal article
- research article
- Published by Wiley in Teratology
- Vol. 33 (1), 21-27
- https://doi.org/10.1002/tera.1420330105
Abstract
The pharmacokinetics of the antiepileptic drug valproic acid (2-proply-pentanoic acid; VPA) and its main active metabolite 2-en-VPA (2-propyl-2-pentenoic acid) in mouse serum and gestational material were studied and correlated with the drastic differences between the two compounds in their embryotoxicity. The peak levels of VPA reached after 0.5 hours were only slightly higher than that of 2-en-VPA (both in mother and gestational material). The free concentrations of VPA and 2-en-VPA in maternal serum also peaked at 0.5 hours. After that time the free maternal serum levels of 2-en-VPA decreased much more rapidly than the concentrations in the gestational materials. The area under the concentration/time curves (AUC) values of 2-en-VPA in mother and embryo were lower than corresponding values of VPA; the higher clearance of 2-en-VPA was predominantly due to an increased volume of distribution. Since we have previously shown that the peak concentrations and not the AUC values of VPA correlated with the teratogenicity of this compound, our present data indicate that the low teratogenic and embryotoxic potential of 2-en-VPA is a result of the intrinsic activity of this compound and not of lower peak concentrations reached in mother and embryo.This publication has 11 references indexed in Scilit:
- SPINA BIFIDA AND IN-UTERO EXPOSURE TO VALPROATEThe Lancet, 1984
- Valproic Acid and Metabolites: Pharmacological and Toxicological StudiesEpilepsia, 1984
- Comparative evaluation of anticonvulsant and toxic potencies of valproic acid and 2-en-valproic acid in different animal models of epilepsyEuropean Journal of Pharmacology, 1984
- Anticonvulsant activity and embryotoxicity of valproic acidNeurology, 1984
- VALPROATE AND BIRTH DEFECTSThe Lancet, 1983
- EMBRYOTOXICITY TESTING OF VALPROIC ACIDThe Lancet, 1983
- Teratogenic effects of valproic acid and diphenylhydantoin on mouse embryos in cultureTeratology, 1983
- A new model for embryotoxicity testing: teratogenicity and pharmacokinetics of valproic acid following constant-rate administration in the mouse using human therapeutic drug and metabolite concentrationsLife Sciences, 1981
- Valproic acid and several metabolites: quantitative determination in serum, urine, breast milk and tissues by gas chromatography—mass spectrometry using selected ion monitoringJournal of Chromatography B: Biomedical Sciences and Applications, 1981
- Teratogenicity of valproic acid: In vivo and in vitro investigationsTeratogenesis, Carcinogenesis, and Mutagenesis, 1981